Industry association · Austria · EU Transparency Register 01523296397-60
3
positions filed
in the 326 files tracked
3
legislative files
of 326 tracked
0
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1205 trade and business associations on this site, they rank #538 by legislative files engaged — a count of participation, not a measure of influence.
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
Register category
Trade and business associations
Head office
Wien, Austria
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Work at Fachverband der Chemischen Industrie Österreichs? so we know who speaks for it.
Their record over time
Fachverband der Chemischen Industrie Österreichs filed 3 positions between 4 Mar 2026 and 5 Aug 2026, across 3 of the 326 legislative files tracked here.
The Association welcomes the European Biotech Act I and strongly supports the objective of making Europe the world’s most attractive location for research, development, clinical trials, manufacturing and scaling of biotech innovations. It is crucial to create a coherent, reliable and internationally competitive framework along the entire value chain.
Filed in German · English published by the European Commission
The FCIO warmly welcomes the Commission’s initiative on a Biotech Act II. The Biotech Act II should be designed as an ambitious, growth- and market-oriented EU framework for relevant knowledge giants, industrial bioeconomy and biotechnological production processes. The aim must be to translate scientific excellence into industrial value creation, employment and sustainable solutions.
Filed in German · English published by the European Commission
FCIO supports a targeted and comprehensive reform of the Biocidal Products Regulation to ensure the harmonisation of the internal market and the availability of effective biocidal products in Europe. High regulatory requirements, lengthy procedures and significant uncertainties in permitting and authorisation processes place a heavy burden on businesses.
Filed in German · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Everything on this page comes from Fachverband der Chemischen Industrie Österreichs’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.